Symbiosis Pharmaceutical Services Revenue
Biotechnology Research • 
Stirling, Scotland, United Kingdom • 101-200 Employees
Symbiosis Pharmaceutical Services revenue & valuation
| Annual revenue | $5,850,000 |
| Revenue per employee | $40,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $18,800,000 |
| Total funding | $2,000,000 |
Key Contacts at Symbiosis Pharmaceutical Services
Colin Mackay
Founder And Chief Executive
Jacqueline Towell
Director Of Business Development
Alison Clayton
Strategic Projects Director
Robert Reekie
Non Executive Director
Lorraine Den-Kaat
Director Of Administration And Hr
Company overview
| Headquarters | Scion House, Stirling Innovation Park, Stirling, Scotland FK9 4NF, GB |
| Phone number | +441786220000 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Lyophilization, Biologics, Liquid, Cytotoxics/Highly Potent Drugs, Sterile Fill Finish, Vial Filling |
| Founded | 2011 |
| Employees | 101-200 |
| Socials |
Symbiosis Pharmaceutical Services Email Formats
Symbiosis Pharmaceutical Services uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@symbiosis-pharma.com), used 72.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@symbiosis-pharma.com | 72.3% |
{first initial}.{last name} | j.doe@symbiosis-pharma.com | 26.7% |
About Symbiosis Pharmaceutical Services
Symbiosis Pharmaceutical Services is a contract manufacturing organisation (CMO) that specialises in the GMP manufacture and sterile fill/finish of vials for clinical trials and low-volume commercial supply. Regulatory compliance, technical capability and operational flexibility are at its core. Manufacturing takes place in a purpose-built MHRA-licensed and FDA approved facility, enabling the CMO to handle products that require aseptic liquid filling and lyophilisation for a range of complex biologics, viral vectors for use in gene therapies and small molecule drugs. Offering fast access to manufacturing slots and accelerated release of drug product, Symbiosis is primed to meet demand for small-scale, fast-turnaround drug product manufacturing, while maintaining regulatory compliance to the highest standards. Symbiosis specialises in the sterile fill/finish of biologic and small molecule products into vials, which are either liquid or lyophilised formulations. Capabilities include the ability to handle and fill antibodies, proteins, peptides, nucleic acids, cytotoxic, cytostatic and highly potent APIs including ADCs along with conventional small molecules. Symbiosis saves our clients invaluable development time. With short lead times to manufacture and faster release of sterile drug product, we get you into phase I/II quickly. Our focus is service excellence through flexibility, responsiveness and timeliness. If you need a drug filled aseptically, come and speak with Symbiosis...we will exceed your expectations.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Symbiosis Pharmaceutical Services has 88 employees across 9 departments.
Departments
Number of employees
Funding Data
Explore Symbiosis Pharmaceutical Services's funding history, including investment rounds, total capital raised, and key backers.
Symbiosis Pharmaceutical Services Tech Stack
Discover the technologies and tools that power Symbiosis Pharmaceutical Services's digital infrastructure, from frameworks to analytics platforms.
Security
Cookie compliance
JavaScript libraries
Miscellaneous
JavaScript libraries
Marketing automation
JavaScript libraries
Web servers
Miscellaneous
Programming languages
Hosting
Germany
Frequently asked questions
4.8
40,000 users
